Dupixent drives a larger share of Sanofi's revenue, with atopic dermatitis, asthma, and CRSwNP as core indications. Learn ...

A Genoa family is using their experience with a chronic condition to help other children better understand what they’re going through. After their son Boden was diagnosed with eosinophilic esophagitis ...

A Genoa family is using their experience with a chronic condition to help other children better understand what they’re going through.

Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-Q) from The Globe and Mail including charting and trades.

Eupraxia Pharmaceuticals Inc. (EPRX) garnered retail attention on Tuesday after the biotech company reported positive data ...

For the first time, Eupraxia is reporting 24-week data on symptom response from the highest dose cohort in the open label, Phase 1b/2a portion of ...

A Topeka boy is marking what may be one of the rarest birthdays in the city this week, turning 13 years old on March 13 — having been born on March 13, 2013.

Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-Q) from The Globe and Mail including charting and trades.

While my list of allergies has ebbed and flowed over the years, my body eventually settled on the relatively small roster of peanuts, tree nuts, dairy, and eggs. The key distinction, though, is that ...

New research shows PPIs can limit fibrosis in eosinophilic oesophagitis, offering potential disease-modifying effects. Learn more about PPI therapy.

Raffle at Upcoming Islanders Game Will Support Eosinophilic Disease Research ATLANTA, GA, UNITED STATES, March 6, ...

Investing.com - Bloom Burton & Co. initiates coverage on Eupraxia Pharmaceuticals (NASDAQ:EPRX) with a buy rating and a price target of $14.00. The firm bases its target on the average of a discounted ...